Ramipril Capsule
Product Images NDC 57237-222

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ramipril (NDC 57237-222). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (1.25 mg (100 Capsule Bottle))

A line graph comparing the proportion of patients over days of follow-up between Ramipril and placebo groups. The x-axis represents days of follow-up from 0 to about 1600, and the y-axis shows the proportion of patients from 0.00 to 0.20. The Ramipril group shows a lower patient proportion increase over time compared to the placebo group. A p-value of 0.0001 is displayed between the two lines, indicating statistical significance.*

FDA Label Image

Package Label-principal Display Panel (2.5 mg (100 Capsule Bottle))

A forest plot chart displaying the relative risk of composite outcomes in the Ramipril group compared to a placebo group across several patient subgroups. The chart includes patient counts and incidence percentages for placebo groups, with a confidence interval scale from 0.6 to 1.2 indicating the relative risk in various conditions such as cardiovascular disease, diabetes, age, sex, hypertension, coronary artery history, and others.*

FDA Label Image

Package Label-principal Display Panel (5 mg (100 Capsule Bottle))

Label for Ramipril Capsules USP 1.25 mg by Rising Pharma Holdings, Inc. The label states the product contains 100 capsules, is prescription only, and includes usage warnings, storage instructions, and distribution details showing Rising Health, LLC in New Jersey. The label also notes the gelatin capsule contains Ramipril USP 1.25 mg and indicates the product is made in India.*

FDA Label Image

Package Label-principal Display Panel (10 mg (100 Capsule Bottle))

The packaging label for Ramipril Capsules, USP 2.5 mg by Rising Pharma Holdings, Inc. shows a box containing 100 capsules. The label includes dosage strength (2.5 mg), storage instructions, pharmacist dispensing warnings, and notes that the capsules are made in India and distributed by Rising Health, LLC in Saddle Brook, NJ. The label also features a barcode and revision date of 12/2017.*

FDA Label Image

Ramipril Fig5

Ramipril Capsules, USP 5 mg bottle label from Rising Pharma Holdings, Inc. The label states the package contains 100 capsules and is for prescription use only. It includes dosing information, storage instructions (20-25°C), a warning to keep out of reach of children, and pharmacist dispensing guidelines. It also notes the product is made in India and distributed by Rising Health, LLC, Saddle Brook, NJ.*

FDA Label Image

Ramipril Fig6

Label for Ramipril Capsules, USP 10 mg from Rising Pharma Holdings, Inc. The label indicates 100 capsules per package, intended for oral use. It includes storage instructions, pharmacist dispensing details, and a warning to keep out of reach of children. The product is distributed by Rising Health, LLC and made in India.*

FDA Label Image

Chemical Structure (Ramipril Str)

Chemical structure of Ramipril, shown as a molecular diagram with labeled chemical bonds and groups, representing the active ingredient's molecular configuration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.